Company Financials

Alliance Pharma plc Financials

Pound sterling

business Alliance Pharma plc Company Profile

Main Stock Listing

LSE: APH

Market Capitalization £329.7 Million as of Jan. 1, 2025

Market Cap History

Valuations Metrics as of May. 5, 2024

Trailing PE 19470.59
Forward PE 0.07
Price to Sales TTM £1.07
Price to Book MRQ £64.52
Enterprise to Revenue 1.63
Enterprise to EBITDA 8.81

Financial Reports as of Jun. 30, 2023

Financials

Fiscal Year Ends 2022-12-31
Most Recent Quarter 2023-06-30
Profit Margin -4.15%
Operating Margin 16.21%
Return on Assets TTM 2.99%
Return on Equity TTM -2.46%

Income Statement

Revenue TTM £170,048,992
Revenue per Share TTM £0.32
Quarterly Revenue Growth 3.30%
Gross Profit TTM £101,683,000
EBITDA £20,753,000
Net Income to Common TTM £-7,059,000
Diluted EPS TTM £-0.01
Quarterly Earnings Growth YoY -61.00%

Balance Sheet

Total Cash MRQ £26,112,000
Total Cash per Share MRQ £0.05
Total Debt MRQ £
Total Debt to Equity MRQ 45.00
Current Ratio MRQ 1.93
Book Value per Share MRQ £0.51

Cash Flow

Operating Cash Flow TTM £29,083,000
Levered Free Cash Flow TTM £19,150,000

APH Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding 540,400,000
Float Shares 525,852,175
Avg 10 Volume 1,882,557
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 11.76%
% Held by Institutions 66.71%

Stock Price Summary

Beta 0.58
Fifty Two Week Low £32.90
Fifty Two Week High £73.04
Fifty Two Week Change -104.53%
Day 50 MA £37.88
Day 200 MA £40.69

Dividends and Splits

Forward Annual Dividend Rate £4.74
Forward Annual Dividend Yield 14.31%
Trailing Annual Dividend Rate £1.18
Trailing Annual Dividend Yield 3.58%
Payout Ratio 1011.76%
Dividend Date
Ex Dividend Date 2023-06-22
Last Split Factor
Last Split Date